The US might require pharma ads to disclose pricing: what marketers need to know

The US Senate recently passed an amendment that would require pharmaceutical companies to list prices of their prescription drugs in direct-to-consumer (DTC) ads. If the Durbin-Grassley amendment makes it through the Congressional reconciliation process intact, it could present some big new complications for pharma marketers in the US. Pharma companies are already required to list …

The US might require pharma ads to disclose pricing: what marketers need to know Read More »